BIOTYPE
Solutions for molecular precision diagnostics – Detect more. Decide better.
BIOTYPE is an innovative German solution provider for molecular precision diagnostics with more that 25 years of experience. We are committed to advancing precision medicine through our products and CDMO services for robust analysis and interpretation of clinical biomarkers.
BIOTYPE offers a strong portfolio in molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, molecular profiling of solid tumors and cell‑ and gene‑therapy applications.
BIOTYPE’s contract development and manufacturing service covers all challenges from the idea up to the realization of a marketable product. As a European Molecular Diagnostic company and a proven CDMO supplier, we are committed to high-quality standards and can accommodate individualized product specifications for our international customers. BIOTYPE‘s quality management system is certified according to DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.
Our mission:
- Provide accessible precision diagnostics and CDMO services for everyone.
- Enable fast and accurate diagnosis of complex diseases and support targeted therapy decisions.
- Improve patient quality of life through molecular biology, technology development, and data analysis.
Our core values:
- Successful Teams: Collaboration, trust, respect, and shared success.
- Customer Focus: Tailored, high-quality solutions with responsive service.
- Quality: ISO 9001 & ISO 13485 certified; continuous improvement.
- Responsibility: Reliable partner; safe and effective products and services.
- Innovation: Development of new solutions for precision diagnostics.
We look forward to the exchange of ideas at the partnering meetings
